Developmental CellCancer BiologyPeer-reviewed journal article
Dysproteostasis primes pancreatic epithelial state changes in KRAS-mediated oncogenesis
Carla Salomo-ColliD, Marisa Di MonacoiD, Jocelyn HolkhamiD, Matthew Denman SmithiD, Morwenna MuiriD, Philippe Emmanuel GautieriD, Hywel Dunn-DaviesiD, Xiaozhong ZhengiD, Roopesh KrishnankuttyiD, Alain J. Kemp, Katie Winnington-Ingram, Alex von KriegsheimiD, Jennifer P. MortoniD, Natalia Jiménez-MorenoiD, Damian J. MoleiD, Simon WilkinsoniD
Abstract
Pre-malignant transformation of pancreatic acinar cells by oncogenic Kras is dependent upon stochastic emergence of metaplastic cell states, through unknown mechanisms. We reveal that an early, transcriptionally-mediated effect of Kras is sporadic failure of proteostatic ER-phagy. Genetically-altered mice deficient in ER-phagy demonstrate that this event co-operates with Kras to drive acinar-ductal metaplasia (ADM) and subsequent cancer. Mechanistically, proteomics and high-resolution imaging uncover pathologic aggregation of a subset of ER proteins, including the injury marker REG3B, resulting from failure to physically interact with the ER-phagy receptor CCPG1. Spatial transcriptomics demonstrate that the appearance of sporadic intracellular aggregates upon Kras activation marks rare acinar cells existing in an injured, ADM-primed state. Importantly, engineered mutants of REG3B establish that aggregate formation is sufficient to directly engender this epithelial cell state. Pancreatic cancer can thus arise from stochastic pathologic protein aggregates that are influenced by and co-operate with an oncogene.
- organism: mouse
- assay: proteomics
- assay: spatial transcriptomics
- research focus: cell type annotation
- research focus: cell-cell communication
- approach: experimental assay
- Citations
- 7
- FWCI
- 4.82
- Field percentile
- top 4%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56α to initiate pancreatic cancer development
S. L. Tinsley, R. A. Shelley, … B. Allen-Petersen·bioRxiv·Jul 1, 2023
- Ductal pancreatic cancer interception by FGFR2 abrogation
Claudia Tonelli, Astrid Deschênes, … David Arthur Tuveson·Cancer ResearchPeer-reviewed·Apr 2, 2025
- STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer
S. D'Amico, V. Kirillov, … N. C. Reich·eLifePeer-reviewed·Apr 4, 2024
- ROR2 regulates cellular plasticity in pancreatic neoplasia and adenocarcinoma
S. Benitz, A. Steep, … H. C. Crawford·bioRxiv·Dec 13, 2023
- Loss of Activating Transcription Factor 3 prevents KRAS-mediated pancreatic cancer
- Extrinsic KRAS signaling shapes the pancreatic microenvironment through fibroblast reprogramming.
A. Velez-Delgado, K. L. Donahue, … M. Pasca di Magliano·bioRxiv·Aug 26, 2021